Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

LIVN vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
LIVN
LivaNova PLC

Medical - Devices

HealthcareNASDAQ • GB
Market Cap$3.62B
5Y Perf.+23.9%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$160.44B
5Y Perf.+133.6%

LIVN vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
LIVN logoLIVN
ISRG logoISRG
IndustryMedical - DevicesMedical - Instruments & Supplies
Market Cap$3.62B$160.44B
Revenue (TTM)$1.43B$10.58B
Net Income (TTM)$107M$2.98B
Gross Margin67.5%66.3%
Operating Margin13.4%30.5%
Forward P/E15.7x43.7x
Total Debt$473M$303M
Cash & Equiv.$636M$3.37B

LIVN vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

LIVN
ISRG
StockMay 20May 26Return
LivaNova PLC (LIVN)100123.9+23.9%
Intuitive Surgical,… (ISRG)100233.6+133.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: LIVN vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ISRG leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. LivaNova PLC is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
LIVN
LivaNova PLC
The Value Play

LIVN is the clearest fit if your priority is value and momentum.

  • Lower P/E (15.7x vs 43.7x)
  • +88.5% vs ISRG's -14.8%
Best for: value and momentum
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 1.02
  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.6% 10Y total return vs LIVN's 30.6%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs LIVN's 10.7%
ValueLIVN logoLIVNLower P/E (15.7x vs 43.7x)
Quality / MarginsISRG logoISRG28.2% margin vs LIVN's 7.5%
Stability / SafetyISRG logoISRGBeta 1.02 vs LIVN's 1.29, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)LIVN logoLIVN+88.5% vs ISRG's -14.8%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs LIVN's 4.2%, ROIC 15.0% vs 11.5%

LIVN vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

LIVNLivaNova PLC
FY 2025
Cardiopulmonary Segment
57.0%$785M
Neuromodulation Segment
43.0%$593M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

LIVN vs ISRG — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGLIVN

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 7.4x LIVN's $1.4B. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to LIVN's 7.5%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricLIVN logoLIVNLivaNova PLCISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$1.4B$10.6B
EBITDAEarnings before interest/tax$220M$3.8B
Net IncomeAfter-tax profit$107M$3.0B
Free Cash FlowCash after capex$161M$2.8B
Gross MarginGross profit ÷ Revenue+67.5%+66.3%
Operating MarginEBIT ÷ Revenue+13.4%+30.5%
Net MarginNet income ÷ Revenue+7.5%+28.2%
FCF MarginFCF ÷ Revenue+11.2%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+14.3%+23.0%
EPS Growth (YoY)Latest quarter vs prior year+106.7%+18.8%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

LIVN leads this category, winning 6 of 6 comparable metrics.

On an enterprise value basis, LIVN's 14.3x EV/EBITDA is more attractive than ISRG's 43.4x.

MetricLIVN logoLIVNLivaNova PLCISRG logoISRGIntuitive Surgica…
Market CapShares × price$3.6B$160.4B
Enterprise ValueMkt cap + debt − cash$3.5B$157.4B
Trailing P/EPrice ÷ TTM EPS-14.89x57.40x
Forward P/EPrice ÷ next-FY EPS est.15.74x43.67x
PEG RatioP/E ÷ EPS growth rate2.64x
EV / EBITDAEnterprise value multiple14.34x43.44x
Price / SalesMarket cap ÷ Revenue2.61x15.94x
Price / BookPrice ÷ Book value/share3.01x9.13x
Price / FCFMarket cap ÷ FCF20.92x64.42x
LIVN leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 8 of 8 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $9 for LIVN. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIVN's 0.39x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs LIVN's 5/9, reflecting solid financial health.

MetricLIVN logoLIVNLivaNova PLCISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity+9.1%+16.9%
ROA (TTM)Return on assets+4.2%+14.8%
ROICReturn on invested capital+11.5%+15.0%
ROCEReturn on capital employed+10.2%+16.5%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage0.39x0.02x
Net DebtTotal debt minus cash-$162M-$3.1B
Cash & Equiv.Liquid assets$636M$3.4B
Total DebtShort + long-term debt$473M$303M
Interest CoverageEBIT ÷ Interest expense3.98x
ISRG leads this category, winning 8 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $16,086 today (with dividends reinvested), compared to $7,915 for LIVN. Over the past 12 months, LIVN leads with a +88.5% total return vs ISRG's -14.8%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.2% vs LIVN's 12.0% — a key indicator of consistent wealth creation.

MetricLIVN logoLIVNLivaNova PLCISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date+9.3%-19.6%
1-Year ReturnPast 12 months+88.5%-14.8%
3-Year ReturnCumulative with dividends+40.6%+49.0%
5-Year ReturnCumulative with dividends-20.8%+60.9%
10-Year ReturnCumulative with dividends+30.6%+556.9%
CAGR (3Y)Annualised 3-year return+12.0%+14.2%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — LIVN and ISRG each lead in 1 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than LIVN's 1.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIVN currently trades 92.1% from its 52-week high vs ISRG's 74.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricLIVN logoLIVNLivaNova PLCISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5001.29x1.02x
52-Week HighHighest price in past year$71.92$603.88
52-Week LowLowest price in past year$35.00$427.84
% of 52W HighCurrent price vs 52-week peak+92.1%+74.8%
RSI (14)Momentum oscillator 0–10033.542.2
Avg Volume (50D)Average daily shares traded814K1.8M
Evenly matched — LIVN and ISRG each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates LIVN as "Buy" and ISRG as "Buy". Consensus price targets imply 37.8% upside for ISRG (target: $623) vs 14.5% for LIVN (target: $76).

MetricLIVN logoLIVNLivaNova PLCISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$75.88$622.60
# AnalystsCovering analysts1455
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+0.1%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LIVN leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

LIVN vs ISRG: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is LIVN or ISRG a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 10. 7% for LivaNova PLC (LIVN). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 4x trailing P/E (43. 7x forward), making it the more compelling value choice. Analysts rate LivaNova PLC (LIVN) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — LIVN or ISRG?

On forward P/E, LivaNova PLC is actually cheaper at 15.

7x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — LIVN or ISRG?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +60. 9%, compared to -20. 8% for LivaNova PLC (LIVN). Over 10 years, the gap is even starker: ISRG returned +556. 9% versus LIVN's +30. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — LIVN or ISRG?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 02β versus LivaNova PLC's 1. 29β — meaning LIVN is approximately 27% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 39% for LivaNova PLC — giving it more financial flexibility in a downturn.

05

Which is growing faster — LIVN or ISRG?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus 10. 7% for LivaNova PLC (LIVN). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to -483. 6% for LivaNova PLC. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — LIVN or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -17. 5% for LivaNova PLC — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 14. 4% for LIVN. At the gross margin level — before operating expenses — LIVN leads at 67. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is LIVN or ISRG more undervalued right now?

On forward earnings alone, LivaNova PLC (LIVN) trades at 15.

7x forward P/E versus 43. 7x for Intuitive Surgical, Inc. — 27. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 8% to $622. 60.

08

Which pays a better dividend — LIVN or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is LIVN or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +556. 9% 10Y return). Both have compounded well over 10 years (ISRG: +556. 9%, LIVN: +30. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between LIVN and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: LIVN is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

LIVN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 5%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform LIVN and ISRG on the metrics below

Revenue Growth>
%
(LIVN: 14.3% · ISRG: 23.0%)
Net Margin>
%
(LIVN: 7.5% · ISRG: 28.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.